Evaluation of biventricular myocardial performance index in patients with Behçet's disease by Çobankara, Veli et al.
The Journal of International Medical Research
2012; 40: 328 – 332
328
Evaluation of Biventricular Myocardial
Performance Index in Patients with
Behçet’s Disease
V COBANKARA1, A GUCLU2, O KURU3, S SENEL1, DS KURU3, H EVRENGUL3 AND
A KAYA4
1Department of Rheumatology, 2Department of Internal Medicine, and 3Department of
Cardiology, Pamukkale University Faculty of Medicine, Denizli, Turkey; 4Department of
Internal Medicine, Division of Rheumatology, Gazi University Faculty of Medicine, 
Ankara, Turkey
OBJECTIVE: The global function of both
left ventricular (LV) and right ventricular
(RV) functions were compared in patients
with Behçet’s disease (BD) versus healthy
controls. METHODS: Biventricular
function was evaluated by measurement
of the myocardial performance index
(MPI) evaluated from tissue Doppler echo -
cardio graphic measurements in 24 BD
patients and was compared with
measurements in 24 age- and sex-matched
healthy controls. RESULTS: Significantly
higher MPI values were associated with
ventricular dysfunction. The study
demonstrated impaired RV function in
patients with BD compared with healthy
controls, whereas normal LV function was
observed both in patients with BD and in
healthy controls. CONCLUSION: Early
noninvasive evaluation of the properties
of BD during the asymptomatic phase of
this inflammatory disease may have
prognostic value in the management of
patients. 
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Introduction
Behçet’s disease (BD) is an autoimmune
disease that was originally described in 1937
by the Turkish dermatologist, Hulusi Behçet,1
and is now recognized as a systemic
vasculitis that can affect arteries and veins.2,3
BD has a progressive course and
encompasses a wide variety of clinical
presentations including those of a vascular,
skin, ocular, joint, neurological, gastro -
intestinal, pulmonary, or cardiovascular
nature.2,3 Cardiac involvement is an
important manifestation of BD that can
cause cardiac pathologies including silent
myocardial ischaemia, pericarditis,
myocarditis, endocarditis, right-sided cardiac
endomyocardial fibrosis, conduction system
disturbances, coronary arteritis, acute
myocardial infarction and dilated
cardiomyopathy.4 – 7
Several studies have investigated
ventricular dysfunction, notably left
ventricular diastolic dysfunction (LVDD), in
patients with BD.8 – 12 Right ventricular (RV)
function has, however, not been extensively
assessed. The myocardial performance index
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(MPI) may be used as a tool to investigate
the global function of both the left and right
ventricles.13,14 The present study compared
cardiac function between patients with BD




The study included consecutive male and
female outpatients with BD who underwent
examinations at the Department of
Rheumatology, Pamukkale University Faculty
of Medicine, Denizli, Turkey, between January
and June 2008. All of these patients fulfilled
the international study group diagnostic
criteria for BD, which requires the presence of
oral ulceration plus any two of genital
ulceration, eye lesions, skin lesions, or a
positive pathergy skin test.15 Patients with BD
included in the study were asymptomatic and
showed no signs of active disease for at least 8
weeks prior to study enrolment, according to
their echocardio graphic evaluations. Healthy
volunteers who were similar to the patient
cohort in terms of age and sex, and who did
not meet the BD diagnostic criteria, were
selected as the control group. Healthy controls
were chosen among persons who were
admitted to the general internal medicine
outpatient clinic in the Pamukkale University
Faculty of Medicine for routine check-up.
Patients and healthy controls with coronary
or valvular heart disease, heart failure (LV
ejection fraction ≤ 60%), atrial fibrillation,
diabetes mellitus, renal failure, chronic
obstructive pulmonary disease, or any other
severe systemic disease were excluded from
the study. 
The study protocol received approval from
the Ethics Committee of Pamukkale
University Faculty of Medicine. All
participants provided written informed
consent prior to inclusion in the study.
ECHOCARDIOGRAPHIC
EVALUATION 
Echocardiography was performed by tissue
Doppler echocardiography (VIVID 7®, GE-
Vingmed, Horten, Norway) using a 3.5 MHz
cardiac probe (VIVID 7®, GE-Vingmed). All
echocardiographic measurements were
performed on the same machine by the same
cardiologist (O.K.) who was blinded to the
study. The measurements were reviewed and
verified by two additional cardiologists
(D.S.K. and H.E.) who were also blinded to the
study. No conflicting measurements were
found during this data verification process.
Isovolumetric contraction time (ICT),
isovolumetric relaxation time (IRT) and
ejection time (ET) were recorded for both
ventricles. Both mitral and tricuspid annular
tissue Doppler measurements were
performed. Apical four-chamber plane was
used for mitral and tricuspid septal and free
wall measurements and apical two-chamber
plane was used for measuring mitral anterior
and posterior annular displacement. The MPI
was calculated with the formula (ICT +
IRT) / ET for each participant.13
STATISTICAL ANALYSES
Statistical analyses were performed using the
SPSS® statistical package, version 11.0 (SPSS
Inc., Chicago, IL, USA) for Windows®.
Continuous variables were summarized as
mean ± SD and categorical variables as
percentages. Comparisons between groups
were assessed with the Student’s t-test. A P-
value < 0.05 was considered to be statistically
significant.
Results 
The study enrolled a total of 24 patients with
BD (17 males, seven females; mean ± SD age
33.8 ± 11.0 years) and 24 age- and sex-
matched healthy controls (17 males, seven
females; mean ± SD age 36.8 ± 11.2 years).
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There were no significant between-group
differences in cardiac risk factors including
diabetes, hypertension, dyslipidaemia and
tobacco consumption (Table 1). 
As shown in Table 2, LV MPI evaluations
were not significantly different between the
patient and control groups. RV MPI evaluations
were significantly greater in patients with BD
than in healthy controls (P < 0.05). There
was no significant difference in MPI between
the male and female patients with BD.
Discussion
Behçet’s disease is recognized as a systemic
vasculitis that affects arteries and veins.2,3
Inflammation of the myocardial microvessels
may lead to myocardial ischaemia and
fibrosis; consequently, disturbances of the
myocardial microcirculation may play a role
in the development of ventricular
dysfunction.7 Pulmonary involvement may
also lead to ventricular dysfunction. Increased
pulmonary vascular resistance may develop
TABLE 1: 
Demographic and clinical characteristics of patients with Behçet’s disease (BD) and
healthy controls evaluated for biventricular myocardial performance index
Patients with BD Healthy controls
Characteristic (n = 24) (n = 24)
Age, years 34 ± 11 37 ± 11
Sex, n (%)
Male 17 (70.8) 17 (70.8)
Female 7 (29.2) 7 (29.2)
BMI, kg/m2 29 ± 4 26.4 ± 6.9
SBP, mmHg 136 ± 5 131 ± 9
DBP, mmHg 78 ± 5 78 ± 4
Smoking, n (%) 19 (79.2) 21 (87.5)
TC, mg/dl 179 ± 7 181 ± 12
TG, mg/dl 151 ± 22 148 ± 20
HDL-C, mg/dl 29 ± 8 30 ± 11
Fasting serum glucose, mg/dl 101 ± 11 99 ± 13
Data presented as mean ± SD, or n (%) patients.
No statistically significance between-group differences (P > 0.05); Student’s t-test.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; TG,
triglyceride, HDL-C, high-density lipoprotein cholesterol.
All participants (n = 48) Patients with BD (n = 24)
Patients Healthy
with BD controls Statistical Males Females Statistical
Parameter (n = 24) (n = 24) significance (n = 17) (n = 7) significance
LV MPI, % 0.4 ± 0.2 0.5 ± 0.1 NS 0.4 ± 0.2 0.3 ± 0.2 NS
RV MPI, % 0.6 ± 0.1 0.4 ± 0.2 P < 0.05 0.6 ± 0.1 0.6 ± 0.1 NS
Data presented as mean ± SD.
NS, no statistically significance between-group differences (P > 0.05); Student’s t-test.
TABLE 2: 
Comparison of left ventricular (LV) and right ventricular (RV) myocardial performance
index (MPI) values in all studied Behçet’s disease (BD) patients versus healthy controls and
in male versus female BD patients
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due to pulmonary vascular or parenchymal
involvement in patients with BD. The right
ventricle is more sensitive to afterload
changes and this sensitivity has led to the
consideration of pulmonary involvement
being a cause of RV dysfunction.16 – 19 The
prevalence of pulmonary manifestations in
BD patients has been reported to be between
1.7% and 7.7%.17 In a study by Ozer et al.,18
high-resolution computed tomography scans
found that 70.6% of the patients with BD had
grade 3 or 4 expiratory air trapping
(indicating the presence of small airway
disease), despite having normal pulmonary
function tests. The study by Ozer et al.18 also
demonstrated a variety of pulmonary
parenchymal changes associated with BD,
including transient focal or diffuse alveolar
infiltrates and wedge-shaped opacities,
reticular infiltrates and parenchymal
hypovascular areas.
Several studies have investigated LVDD in
BD. Komsuoglu et al.8 found LVDD in 22%
(5/22) of the patients with BD who were
assessed. Other studies by Çalguneri et al.9
and Gemici et al.10 also demonstrated
comparable LVDD rates in patients with BD
(37% [9/24] and 30% [22/71], respectively).
In the latter study by Gemici et al.,10 patients
with BD had a significantly higher incidence
of impaired mitral ratio of peak early-to-late
diastolic filling velocity and significantly
longer LV isovolumic relaxation and mitral
deceleration times compared with healthy
controls. On the other hand, Kirimli et al.20
found no difference between the patient and
healthy control groups regarding heart rate
variability measurements, suggesting there
is no clear involvement of autonomic
abnormality in BD. A study by Tavil et al.,12
which evaluated tissue Doppler-derived MPI,
found impaired LV MPI in patients with BD,
although systolic and diastolic function
parameters were comparable in the patient
and control groups.
The present study measured MPI using
tissue Doppler echocardiography in order to
evaluate LV and RV global function in
patients with BD compared with healthy
controls. The MPI has been described by Tei13
and represents both systolic and diastolic
ventricular function. It is an easy,
reproducible, reliable and relatively objective
noninvasive method to obtain data on
ventricular function.13 In contrast to the
findings by Tavil et al.,12 the present study
demonstrated increased RV MPI in patients
with BD but normal LV MPI. The reasons for
such contrasting findings between the two
studies remain unclear. One potential
explanation may concern the higher
percentage of male patients with BD enrolled
in the present study (70.8%) compared with
45.2% of male patients enrolled in the study
by Tavil et al.12 A possible gender effect
remains to be elucidated.  
There were some limitations to the present
study including the relatively small numbers
of patients with BD and healthy controls
enrolled, and the short duration of follow-up
for each participant. Future studies, enrolling
larger numbers of patients in different
phases of the disease course, would enable
further investigation into the role of MPI and
RV function in the screening and treatment
of patients with BD.  
In summary, the present study
demonstrated impaired RV MPI and normal
LV MPI in BD patients. Early noninvasive
evaluation of the properties of this
inflammatory disease, with accompanying
vasculitis in the asymptomatic phase, may
have a prognostic value in the management
of BD. 
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